LEP and metabolic disease: Gene Oncology (GO) Biological Process analysis was then performed and the results revealed DEGs were enriched in biological processes related to metabolic disease risk including “inflammatory response”, “lipid metabolism process”, and “cellular response to leptin stimulus”.